<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04642729</url>
  </required_header>
  <id_info>
    <org_study_id>EyeHP</org_study_id>
    <nct_id>NCT04642729</nct_id>
  </id_info>
  <brief_title>Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery</brief_title>
  <official_title>Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex-Smile Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye Hospital Pristina Kosovo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye Hospital Pristina Kosovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to examine the effect of fresh corneal lenticule implantation as&#xD;
      allogenic graft taken from myopic patients to implanted in patients with macular corneal&#xD;
      dystrophy using Visumax Femtosecond Laser Smile module surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Macular Corneal Dystrophy is a severe form of stromal corneal dystrophy characterized by&#xD;
      bilateral cloudy regions within hazy stroma and eventually severe visual impairment.&#xD;
&#xD;
      Most cases of MCD are caused by mutations in the CHST6 gene encoding a protein involved in&#xD;
      the production of keratan sulfate, which plays a role in the maintenance of corneal&#xD;
      transparency.&#xD;
&#xD;
      According to biomechanical instability of corneal metabolism (abnormal increase collagenase&#xD;
      activity, decrease proteinase inhibitors, excessive premature keratocyte apoptosis, increase&#xD;
      cytokine binding) at corneal dystrophies. Fresh Corneal Lenticule and autologous serum&#xD;
      contains live stem cells that produce keratocytes, collagen fibers, extracellular matrix&#xD;
      which contribute to the regeneration of the cornea, and all this results at increasing of&#xD;
      corneal transparency and visual acuity in patients with corneal macular dystrophy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2024</completion_date>
  <primary_completion_date type="Actual">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of corneal transparency</measure>
    <time_frame>12 months</time_frame>
    <description>Implanting fresh corneal lenticule we add more live stem cells and keratocytes to stabilize biomechanical stability of cornea. Also making flap and putting autologous serum after one month of implanting fresh corneal lenticule we removed more dead keratocytes from macula dystrophia and added more live keratocytes which contributed to the regeneration of the cornea.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase of visual acuity</measure>
    <time_frame>12 months</time_frame>
    <description>After implanting fresh corneal lenticule according to clarity of cornea visual acuity increased for 2-3 m and also softening symptoms of corneal dystrophy ex. dry eyes, sensitivity to light, pain in the eye, corneal erosion etc.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Macular Corneal Dystrophy</condition>
  <arm_group>
    <arm_group_label>ReLex Smile surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The myopic lenticule after Relex Smile surgery is put into BBS solution for 10 min. Under topical anesthesia, Using VisuMax Femtosecond Laser.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fresh corneal lenticule implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Using VisuMax Femtosecond Laser we make intrastromal pocket incision 2-3 mm in periphery of cornea (Because the macular dystrophy is in the center more progressive) and 150 µm deep to put fresh corneal lenticule. After one month using VisuMax we create a flap using autologous serum with purpose to remove more dead keratocytes and adding live keratocytes with aim to regenerate the metabolism of cornea.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fresh Corneal Lenticule Implantation using Relex-Smile Surgery</intervention_name>
    <description>Knowing that the most important element is damage of stroma we used all preoperative procedures atlas, optic tomography and especially electron microscope. Approximately we planned how much microns we remove and insert, for example we remove 80 µm and we insert fresh corneal lenticule 90 µm with the purpose to remove more dead keratocytes which increase biomechanical instability of corneal metabolism (abnormal increase collagenase activity, decrease proteinase inhibitors, excessive premature keratocyte apoptosis, increase cytokine binding). Fresh Corneal Lenticule and autologous serum contains live stem cells that produce keratocytes, collagen fibers, extracellular matrix which contribute to the regeneration of the cornea, and all this results at increasing of corneal transparency and visual acuity in patients with corneal macular dystrophy.</description>
    <arm_group_label>ReLex Smile surgery</arm_group_label>
    <arm_group_label>fresh corneal lenticule implantation</arm_group_label>
    <other_name>Relex smile surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  indications for penetrating keratoplasty&#xD;
&#xD;
          -  low transparec of corneae&#xD;
&#xD;
          -  low visual acuity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active anterior segment pathology&#xD;
&#xD;
          -  previous corneal or anterior segment surgery&#xD;
&#xD;
          -  any infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital Pristina</name>
      <address>
        <city>Pristina</city>
        <zip>10000</zip>
        <country>Kosovo</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kosovo</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 20, 2020</study_first_submitted>
  <study_first_submitted_qc>November 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2020</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eye Hospital Pristina Kosovo</investigator_affiliation>
    <investigator_full_name>Dr. Faruk Semiz</investigator_full_name>
    <investigator_title>Head of Ophthalmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Dystrophies, Hereditary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

